- Home
- MGNX
MGNX
MacroGenics Inc.
as 11-22-2024 4:00pm EST
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. Its pipeline MGC018 (B7-H3), Lorigerlimab (PD-1 x CTLA-4), Tebotelimab (PD-1 x LAG-3), MGD024 (CD123 x CD3), IMGC936 (ADAM9), Enoblituzumab (anti-B7-H3), Retifanlimab (PD-1), and MGD014 (HIV x CD3).
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | Rockville |
| Market Cap: | 257.3M | IPO Year: | 2013 |
| Target Price: | $8.57 | AVG Volume (30 days): | 770.4K |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.56 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.95 - $21.88 | Next Earning Date: | 11-05-2024 |
| Revenue: | $141,329,000 | Revenue Growth: | 16.68% |
| Revenue Growth (this year): | 119.63% | Revenue Growth (next year): | -30.34% |
Latest MacroGenics Inc. News
MGNX Breaking Stock News: Dive into MGNX Ticker-Specific Updates for Smart Investing
MT Newswires
16 days ago
JMP Securities Downgrades MacroGenics to Market Perform
Simply Wall St.
17 days ago
MacroGenics Third Quarter 2024 Earnings: Beats Expectations
GlobeNewswire
17 days ago
MacroGenics to Participate in Upcoming Investor Conferences
Thomson Reuters StreetEvents
17 days ago
Q3 2024 MacroGenics Inc Earnings Call
GuruFocus.com
18 days ago
Macrogenics Inc (MGNX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Developments
Motley Fool
18 days ago
MacroGenics (MGNX) Q3 2024 Earnings Call Transcript
Zacks
18 days ago
Here's What Key Metrics Tell Us About MacroGenics (MGNX) Q3 Earnings
Zacks
18 days ago
MacroGenics (MGNX) Beats Q3 Earnings and Revenue Estimates
Compare MGNX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MGNX MacroGenics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.